On June 21, 2016, the Board of Directors of Genomic Health Inc. increased the authorized number of members of the Board of Directors of the company to eight and elected Geoffrey M. Parker a member of the Board of Directors of the company. In addition, Mr. Parker will serve on the Audit Committee of the Board of Directors. Mr. Parker served as the Executive Vice President and Chief Financial Officer of Anacor Pharmaceuticals Inc. from May 2014 to May 2015 and was Senior Vice President and Chief Financial Officer at Anacor from September 2010 to May 2014. From April 1997 to April 2009, Mr. Parker was a Vice President, Managing Director and Partner at the global investment banking and securities firm Goldman, Sachs & Co. Mr. Parker is currently a member of the board of directors of ChemoCentryx Inc. and Sunesis Pharmaceuticals Inc.